Levin E R, Hu R M, Rossi M, Pickart M
Department of Medicine, University of California, Irvine 92717.
Endocrinology. 1992 Sep;131(3):1417-23. doi: 10.1210/endo.131.3.1380442.
The central nervous system modulates cardiovascular function and fluid and electrolyte balance in part through the actions of vasoactive peptides/neurotransmitters. The presence of several vasoactive peptides and their receptors in the hypothalamus suggests a possible interaction at this site. One level at which vasoactive peptides such as arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) might interact is through the mutual regulation of production and secretion in the hypothalamus. To determine whether AVP modulates ANP gene expression and secretion, we cultured fetal rat diencephalic neurons in the presence of AVP. AVP induced a significant increase in ANP secretion in dose-related fashion (mean +/- SEM basal ANP, 87 +/- 4 pg/ml; maximal mean AVP-stimulated ANP, 146 +/- 6 pg/ml; P less than 0.05, by analysis of variance). Neither oxytocin nor the vasoactive neuropeptide angiotensin-II had any effect on ANP secretion. The stimulatory effect of AVP was significantly blocked by coincubation with a V1 receptor antagonist, but was unaffected by a V2 receptor antagonist. The immunoreactive ANP secreted in response to AVP was the major brain isoform, ANP-(103-126). Coincubation with a calcium channel antagonist, nifedipine, had no effect on AVP-induced ANP secretion, while ryanodine, an inhibitor of intracellular calcium mobilization, significantly reduced the stimulatory effect of AVP. AVP induced a dose-related, nearly 3-fold maximal increase in ANP mRNA expression at 4 h. Coincubation of the neurons with a V1 receptor antagonist also significantly attenuated the increased ANP gene expression induced by AVP. These results indicate that AVP acts directly through V1 receptors on cultured fetal rat diencephalic neurons to augment ANP gene expression and secretion of the peptide. The effects are probably related to AVP-stimulated mobilization of intracellular calcium and not the result of calcium influx into the cell. These studies provide the first evidence that AVP modulates ANP production from cultured neurons. In the central nervous system, these two vasoactive neuropeptides might interact in part through the regulation of ANP production by AVP.
中枢神经系统部分通过血管活性肽/神经递质的作用来调节心血管功能以及体液和电解质平衡。下丘脑存在多种血管活性肽及其受体,提示在此部位可能存在相互作用。血管活性肽如精氨酸加压素(AVP)和心房利钠肽(ANP)可能相互作用的一个层面是通过下丘脑内产生和分泌的相互调节。为了确定AVP是否调节ANP基因表达和分泌,我们在AVP存在的情况下培养胎鼠间脑神经元。AVP以剂量相关方式显著增加ANP分泌(基础ANP的平均值±标准误,87±4 pg/ml;AVP刺激后的最大平均ANP,146±6 pg/ml;方差分析,P<0.05)。催产素和血管活性神经肽血管紧张素-II对ANP分泌均无影响。与V1受体拮抗剂共同孵育可显著阻断AVP的刺激作用,但V2受体拮抗剂对其无影响。对AVP作出反应而分泌的免疫反应性ANP是主要的脑异构体,即ANP-(103 - 126)。与钙通道拮抗剂硝苯地平共同孵育对AVP诱导的ANP分泌无影响,而细胞内钙动员抑制剂ryanodine则显著降低AVP的刺激作用。AVP在4小时时诱导ANP mRNA表达呈剂量相关的近3倍最大增加。神经元与V1受体拮抗剂共同孵育也显著减弱了AVP诱导的ANP基因表达增加。这些结果表明,AVP通过V1受体直接作用于培养的胎鼠间脑神经元,以增强ANP基因表达和该肽的分泌。其作用可能与AVP刺激的细胞内钙动员有关,而非钙流入细胞的结果。这些研究提供了首个证据表明AVP调节培养神经元中ANP的产生。在中枢神经系统中,这两种血管活性神经肽可能部分通过AVP对ANP产生的调节而相互作用。